Maat Biotech Private Limited

Maat Biotech Private Limited - life sciences in Bhiwadi, Rajasthan, India. Directors, charges & compliance details.
CIN U36990RJ2021PTC073328 Incorporated 06 February 2021 ROC Jaipur HQ Bhiwadi, Rajasthan, India
Active Private Limited Company life sciences Startup India MSME · Micro
Data last updated
Revenue · FY 2024
₹9.22 Lakh
▲ 158% YoY
Net loss · FY 2024
₹57.66 Lakh
Latest filing
EBITDA · FY 2024
-₹42.24 Lakh
EBITDA margin -458.2%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.43 Cr
Issued & subscribed
Company age
5 yrs
Est. 2021
Employees · EPFO
7
Provident fund records
Directors on board
2
As per MCA filings

About Maat Biotech Private Limited

Data last updated:

Maat Biotech Private Limited is a private limited company based in Bhiwadi, Rajasthan, India, recognised as a startup by DPIIT. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 06 February 2021 and has been in existence for over 5 years.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U36990RJ2021PTC073328.

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.43 Cr. It is led by directors Bhaskar Mukherjee and Susmita Chatterjee.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at H1 – 477 B RIICO Industrial Area Khushkhera, Bhiwadi, Rajasthan, India – 301707.

As per the financials filed for FY 2024, the company reported a revenue of ₹9.22 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹57.66 Lakh and EBITDA of -₹42.24 Lakh (EBITDA margin -458.2%).

The company has about 7 employees on its provident fund (EPFO) records.

Maat Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-RJ-02-0016319).

Company details

CIN U36990RJ2021PTC073328
Registration Number 073328
Incorporation Date 06 February 2021
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-RJ-02-0016319

Recognitions & Rankings of Maat Biotech

Startup India Government of India
MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-RJ-02-0016319

Contact details

Maat Biotech Private Limited's registered office is in Bhiwadi, Rajasthan.

  • Registered Address
    H1 – 477 B RIICO Industrial Area Khushkhera, Bhiwadi, Rajasthan, India – 301707
  • Industry
    Life Sciences, Biotechnology
Comprehensive company report
Maat Biotech Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Maat Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Maat Biotech Private Limited, buy the company report.

Financials of Maat Biotech Private Limited

FY 2025 filings available

Maat Biotech Private Limited reported revenue of ₹9.22 Lakh (up 158% YoY) for FY 2024.

Revenue · FY 2024
₹9.22 Lakh ▲ 158%
Net loss · FY 2024
₹57.66 Lakh
EBITDA · FY 2024
-₹42.24 Lakh margin -458.2%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 158%
EBITDA CAGR growth
1 year
▲ 15%

Revenue rose 158% in the latest year. EBITDA rose 15% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹42.24 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹57.66 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-458.2%
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Maat Biotech Private Limited, buy the company report.

Board of directors of Maat Biotech Private Limited

Maat Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Bhaskar MukherjeeDirector14 Mar 20242 Years 7 MonthsCurrent
Susmita ChatterjeeDirector06 Feb 20215 Years 9 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Maat Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Maat Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Maat Biotech Private Limited has 3 board changes on record since 2021: 2 appointments and 1 cessation. The latest: Bhaskar Mukherjee was appointed as Director on 14 Mar 2024.

AGM
Maat Biotech Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Maat Biotech Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Appointed
Bhaskar Mukherjee was appointed as Director.
Ceased
Ujaan Mukherjee ceased to be Director.
Appointed
Susmita Chatterjee was appointed as Director.
Incorporation
06 Feb 2021
Maat Biotech Private Limited was registered on 06 Feb 2021 with Roc Jaipur & aged 5 years 9 months as per MCA records.

Frequently asked questions

Maat Biotech is an active private limited company based in Bhiwadi, Rajasthan, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 06 February 2021 (5+ years old) and is registered under CIN U36990RJ2021PTC073328.

Maat Biotech has 2 current directors:

The latest financial statements of Maat Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.

The CIN (Corporate Identification Number) of Maat Biotech is U36990RJ2021PTC073328. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Maat Biotech was incorporated on 06 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Jaipur.

Bhaskar Mukherjee was appointed as Director on 14 Mar 2024. Ujaan Mukherjee ceased to be Director on 14 Mar 2024. Susmita Chatterjee was appointed as Director on 06 Feb 2021.

Yes, Maat Biotech is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

Yes, Maat Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-RJ-02-0016319).

The registered office of Maat Biotech is at H1 – 477 B RIICO Industrial Area Khushkhera, Bhiwadi, Rajasthan, India – 301707.

Maat Biotech operates in the life sciences industry, in the biotechnology segment.